IMGN388

· ImmunoGen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMGN388, covering 2013-09-13 to 2013-09-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors [Phase 1]